Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Fresenius Medical Care Corporation

Healthcare US FMS

22.015USD
0.09(0.39%)

Last update at 2026-06-05T20:00:00Z

Day Range

21.9322.11
LowHigh

52 Week Range

20.9529.71
LowHigh

Fundamentals

  • Previous Close 21.93
  • Market Cap12798.54M
  • Volume512536
  • P/E Ratio11.65
  • Dividend Yield3.55%
  • EBITDA2622.43M
  • Revenue TTM19627.60M
  • Revenue Per Share TTM33.70
  • Gross Profit TTM 5028.93M
  • Diluted EPS TTM1.97

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1512.00M 1056.93M 1033.02M 1220.00M 1572.00M
Minority interest -212.90000M -202.95700M -233.46100M -222.00000M -250.00000M
Net income 978.00M 537.91M 499.00M 673.00M 969.00M
Selling general administrative 3032.73M 2366.29M 2388.38M 3784.00M 3096.00M
Selling and marketing expenses - 776.53M 807.96M - -
Gross profit 5029.00M 4756.65M 4925.01M 5310.00M 5077.00M
Reconciled depreciation 1500.41M 1742.26M 1751.97M 1838.36M 1623.68M
Ebit 1512.00M 1463.97M 1457.65M -258.36300M 301.32M
Ebitda 2956.96M 3206.23M 3209.63M 1580.00M 1925.00M
Depreciation and amortization 1444.96M 1742.26M 1751.97M 1838.36M 1623.68M
Non operating income net other - - - - -
Operating income 1827.00M 1392.39M 1369.44M -258.36300M 301.32M
Other operating expenses 17801.00M 17943.51M 18084.18M 18101.00M 15859.00M
Interest expense 384.41M 407.04M 424.64M 360.00M 353.00M
Tax provision 320.97M 316.06M 300.56M 325.00M 353.00M
Interest income 69.61M 71.58M 88.22M 68.00M 280.00M
Net interest income -314.79800M -335.46900M -336.42300M -292.00000M -280.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 321.00M 316.06M 300.56M 325.00M 353.00M
Total revenue 19628.00M 19335.91M 19453.62M 19398.00M 17619.00M
Total operating expenses 3202.00M 3364.26M 3555.57M 4013.00M 3317.00M
Cost of revenue 14599.00M 14579.26M 14528.61M 14088.00M 12542.00M
Total other income expense net -315.00000M -335.46900M -336.42300M 1478.36M 1270.68M
Discontinued operations - - - - -
Net income from continuing ops 1191.27M 740.87M 732.46M 895.00M 1219.00M
Net income applicable to common shares 978.37M 537.91M 499.00M 673.40M 969.31M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 31002.00M 33566.58M 33929.81M 35754.00M 34367.00M
Intangible assets 14826.00M 1370.08M 1362.33M 1518.68M 1459.39M
Earning assets - - - - -
Other current assets 1016.00M 1102.51M 1326.39M 351.05M 342.89M
Total liab 16719.00M 17798.07M 19103.27M 20305.00M 20388.00M
Total stockholder equity 14283.00M 14576.56M 13620.26M 15449.00M 13979.00M
Deferred long term liab - - - - -
Other current liab 3310.00M 3092.67M 3247.20M 3393.04M 3297.44M
Common stock 14283.00M 293.41M 293.41M 293.41M 293.00M
Capital stock 293.41M 293.41M 293.41M 293.41M 293.00M
Retained earnings 12207.91M 11266.29M 10921.69M 10711.71M 10826.14M
Other liab - - - 2661.95M 2395.14M
Good will 13571.39M 15170.65M 14650.01M 15791.18M 14361.58M
Other assets 454.77M 427.83M 507.53M 1127.27M 1239.97M
Cash 1599.00M 1180.19M 1403.49M 1273.79M 1481.65M
Cash and equivalents 669.42M 342.86M 324.43M 362.77M 556.52M
Total current liabilities 6245.00M 5660.06M 6111.59M 6467.00M 7258.00M
Current deferred revenue - 82.17M 85.82M 105.72M 518.03M
Net debt 9196.00M 9824.04M 10673.80M 11938.78M 11838.34M
Short term debt 2197.00M 1218.27M 1561.56M 2036.90M 2585.00M
Short long term debt 1613.04M 577.38M 944.60M 1363.08M 1924.00M
Short long term debt total 10795.00M 11004.22M 12077.29M 13212.57M 13320.00M
Other stockholder equity -1591.58600M 3345.41M 3380.33M 4832.35M 4171.49M
Property plant equipment 6499.80M 7258.58M 7454.02M 8339.81M 8551.47M
Total current assets 7898.00M 7922.74M 8701.41M 8203.00M 7967.00M
Long term investments 1323.48M 1416.69M 1254.51M 773.72M 786.90M
Net tangible assets - - - -3320.40500M -3122.18700M
Short term investments 238.77M 163.09M 154.37M 169.98M 136.36M
Net receivables 3142.00M 3409.03M 3637.99M 4031.60M 3906.68M
Long term debt 5691.85M 6260.82M 6959.86M 7170.73M 6647.00M
Inventory 2141.00M 2067.92M 2179.18M 2296.21M 2038.01M
Accounts payable 738.00M 984.32M 885.15M 931.34M 857.53M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -328.54500M -975.16900M -388.46800M -1311.63700M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 5264.00M 720.02M 681.83M 4967.60M 5160.73M
Deferred long term asset charges - - - - -
Non current assets total 23104.00M 25643.83M 25228.40M 27551.00M 26400.00M
Capital lease obligations 3490.71M 4140.70M 4145.95M 4678.76M 4749.00M
Long term debt total 8598.27M 9760.64M 10488.85M 11175.67M 10734.75M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -4.02400M -84.93900M -672.67100M -734.72500M -61.57500M
Change to liabilities - - - -356.78900M -363.95500M
Total cashflows from investing activities -666.17553M -84.93900M -544.22700M -734.72500M -1196.22800M
Net borrowings 149.58M -1905.14900M -1189.79300M -1023.04500M -358.90300M
Total cash from financing activities -1375.66436M -2569.30000M -1858.52900M -1617.36000M -1024.38200M
Change to operating activities - - - 154.03M 164.20M
Net income 939.75M 740.87M 732.46M 895.00M 1219.00M
Change in cash 558.32M -241.89700M 153.44M -207.86800M 400.12M
Begin period cash flow 1040.12M 1427.22M 1273.79M 1481.65M 1081.54M
End period cash flow 1598.43M 1185.33M 1427.22M 1273.79M 1481.65M
Total cash from operating activities 2575.19M 2386.14M 2628.80M 2167.00M 2489.00M
Issuance of capital stock - - - - -
Depreciation 1405.66M 1742.26M 1751.97M 1838.36M 1623.68M
Other cashflows from investing activities -666.17553M 14.10M 16.14M 35.61M -309.51300M
Dividends paid 405.84M 349.16M 328.62M -395.55600M -392.45500M
Change to inventory -238.84414M 107.90M -13.14000M -204.30700M -48.53000M
Change to account receivables -66.33535M -73.47700M -151.84400M -46.68200M -163.19700M
Sale purchase of stock -562.18538M 0.00000M 0.00000M 20.15M 6.51M
Other cashflows from financing activities -1174.74013M -314.98900M -340.11300M 1600.22M 2775.28M
Change to netincome - - - -98.09300M 32.59M
Capital expenditures 879.24M 699.36M 684.60M 1411.00M 1683.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 132.78M 444.31M 561.28M -566.00000M -354.00000M
Stock based compensation - - 32.52M - -1690.93500M
Other non cash items 123.13M -468.62400M -327.27000M 41.11M 1624.00M
Free cash flow 1695.95M 1686.79M 1944.20M 756.00M 806.00M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
FMS
Fresenius Medical Care Corporation		 0.09 0.39% 22.02 11.65 9.33 0.65 0.80 1.00 5.77
HCA
HCA Healthcare, Inc.		 10.30 2.85% 372.13 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.04 0.37% 10.75 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 - -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care Corporation

Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352

Key Executives

Name Title Year Born
Ms. Helen Giza CEO, Chief Transformation Officer, Acting CFO & Chair of Mgmt Board of Fresenius Med. Care Mgmt AG 1968
Mr. Robert Maurice Powell Jr. Member of the Management Board of Fresenius Medical Care Management AG 1955
Dr. Franklin W. Maddux F.A.C.P. Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG 1957
Mr. William J. Valle Management Board Member for Care Delivery of Fresenius Medical Care Management AG 1960
Dr. Katarzyna Mazur-Hofsab Ph.D. Management Board Member for Care Enablement of Fresenius Medical Care Management AG 1963
Mr. Roberto Fuste Exec. Advisor for Regional Strategy 1952
Dr. Nwamaka Eneanya M.D. Head of Strategy & Operations NA
Dr. Dominik Heger Exec. VP and Head of Investor Relations, Strategic Devel. & Communications NA
Mr. Borries Von Muller Sr. VP of Global HR Employee Communications 1961
Mr. Joachim Weith Sr. VP of Corp. Communications & Gov.al Affairs NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.